Mr. Speaker, our government is committed to improving access to necessary prescription medication, including orphan drugs, as we understand the difficulties experienced by people dealing with rare diseases. We are working on improving access to orphan drugs. We have, as I said earlier, launched a regulatory review of drugs and devices initiative and we encourage people with rare diseases to work with the implementation of a national pharmacare council to give advice to the development of those recommendations.
In the House of Commons on September 28th, 2018. See this statement in context.